DocsApp looks to cure fund woes with Rs 36 crore from Bessemer https://t.co/NKpKX11T7Y via @economictimes — The Propell Group (@ThePropellGroup) October 5, 2017
Multi-omic data analytics collaboration between the University of Oxford and Holmusk | Markets Insider https://t.co/WoCKXTxpXF — The Propell Group (@ThePropellGroup) October 5, 2017
Games for people with disabilities https://t.co/rnwkbK7mfu — The Propell Group (@ThePropellGroup) October 4, 2017
When two worlds collide — big pharma meets big tech https://t.co/acbW9F26nI — The Propell Group (@ThePropellGroup) October 3, 2017
In digital health’s biggest year of funding, women CEOs emerge as Q3 2017 winners | Rock Health #healthtech https://t.co/MfnpiqiGJd — The Propell Group (@ThePropellGroup) October 3, 2017 #healthtech
Softbank-backed Roivant to invest in hepatitis-B drug specialist via @FThttps://t.co/ipiF1iLqM0 — The Propell Group (@ThePropellGroup) October 3, 2017 #healthtech
Round 2 of the @GalenGrowthAsia Most Innovative Asia #HealthTech startup starts today! https://t.co/cFSJYpM39e — The Propell Group (@ThePropellGroup) October 3, 2017 #healthtech
A New Drug Uses CRISPR to Fight Antibiotic-Resistant Bacteria https://t.co/BCoag8svHG — The Propell Group (@ThePropellGroup) October 2, 2017 #healthtech
China’s Wuxi Healthcare Ventures leads $55m Series A in US-based LifeMine Therapeutics: https://t.co/UWX4pCbmuT — The Propell Group (@ThePropellGroup) October 2, 2017 #healthtech
Practo map shows urban Indians have a weak heart #HealthTech https://t.co/m4Ec7qGQXj — The Propell Group (@ThePropellGroup) October 1, 2017 #healthtech